Acireductone dioxygenase (ARD) from the methionine salvage pathway of Klebsiella oxytoca is the only known naturally occurring metalloenzyme that catalyzes different reactions in vivo based solely on the identity of the divalent transition metal ion (Fe 2+ or Ni 2+ ) bound in the active site. The ironcontaining isozyme catalyzes the cleavage of substrate 1,2-dihydroxy-3-keto-5-(thiomethyl)pent-1-ene (acireductone) by O 2 to formate and the ketoacid precursor of methionine, whereas the nickelcontaining isozyme uses the same substrates to catalyze an off-pathway shunt to form methylthiopropionate, carbon monoxide and formate. This dual chemistry was recently demonstrated in vitro by ARD from Mus musculus (MmARD), providing the first example of a mammalian ARD exhibiting metal-dependent catalysis. We now show that human ARD (HsARD) is also capable of metaldependent dual chemistry. Recombinant HsARD was expressed and purified to obtain a homogeneous enzyme with a single transition metal ion bound. -bound HsARD being the least stable. As with the bacterial ARD, solution NMR data suggest that HsARD isozymes can have significant structural differences depending upon the metal ion bound.
Introduction
The methionine salvage pathway (MSP) is a ubiquitous pathway found in bacteria, plants and animals. The MSP is essential, recycling the methylthio group of methionine and regulating the concentration of several intermediates in the pathway. The first step in the MSP involves enzymatic synthesis of S-adenosylmethionine (SAM) from methionine and ATP ( Fig. 1) (Pochapsky et al., 2007) . SAM is involved in the synthesis of spermine and spermidine in animals and ethylene in plants. Polyamines are required for cell growth and proliferation (William-Ashman and Pegg, 1981) while ethylene is required for fruit and vegetable ripening (Taiz, 1991) . Defects in polyamine regulation are associated with defects in cell cycle, cell growth and DNA replication (Oredsson, 2003) . Methylthioadenosine (MTA) is an intermediate formed from SAM during polyamine and ethylene synthesis, and is an inhibitor of polyamine synthesis (WilliamAshman and Pegg, 1981; Williams-Ashman et al., 1982) . Inhibition of polyamine synthesis arrests DNA replication whereas elevated polyamine levels are associated with suppression of apoptosis and tumor formation (Pegg, 1988; Marton and Pegg, 1995) . Hence the intracellular levels of MTA are tightly regulated, and the MSP is critical in maintaining MTA homeostasis (Shapiro and Barrett, 1981) .
Acireductone dioxygenase (ARD) catalyzes the penultimate step in the pathway, the oxidative decomposition of substrate acireductone (1, 2-dihydoxy-3-keto-5-(thiomethyl) pent-1-ene) to formate and 2-keto-4-(thiomethyl) butyrate (KMTB). It represents a branch point in the MSP of the bacterium Klebsiella oxytoca: when Fe 2+ is bound, ARD catalyzes on-pathway chemistry, but when Ni 2+ is bound, it catalyzes an off-pathway shunt leading to production of carbon monoxide, formate and 3-methylthiopropionate (Wray and Abeles, 1995; Dai et al., 1999) . Both these forms of ARD have been isolated from native K. oxytoca (Myers et al., 1993) , and are also obtained upon overexpression in Escherichia coli. The activities of the two enzymes can be interconverted by replacement and reconstitution with the appropriate metal (Chai et al., 2008) . These represent the only known pair of naturally occurring metalloenzymes with distinct functions determined solely by the metal ion identity in the active site. The purpose of the off-pathway chemistry catalyzed by Ni 2+ -ARD in K. oxytoca is unknown. The solution structures of the two isoforms of ARD from K. oxytoca have been characterized by NMR. In the Ni
2+
-bound form (Ni-KoARD), the active site was modeled by X-ray absorption spectroscopy due to paramagnetism of the bound metal ion (Pochapsky et al., 2002) . The structure of the Fe 2+ -bound form (Fe-KoARD) is a model based on the structure of a stable metal-free mutant of H98S ARD (Ju et al., 2006) .
Recently, a mammalian ARD from Mus musculus (MmARD) was shown to exhibit dual chemistry similar to ARD from K. oxytoca (Deshpande et al., 2016) and Co 2+ -bound forms of MmARD are structurally similar. The metal in both cases is present in a distorted octahedral coordination geometry in the active site bound to protein ligands H88, H90, H133 and E94 (Fig. 2) . In addition to the protein ligands, there are two distinct water ligands bound to the metal ion center. Structures of Ni
-bound MmARD bound to product and substrate analogs provided insight into substrate binding in the active site, metal coordination and catalytic mechanism (Xu et al., 2006; Deshpande et al., 2016) .
Several studies have shown ARD to serve other functions in mammals in addition to its enzymatic function. An N-terminal truncated version of human ARD (HsARD), referred to as SipL, is implicated in the replication of hepatitis C virus in non-permissive cell lines (Yeh et al., 2001) . SipL lacks the first 63 amino acids of fulllength HsARD. HsARD is also known to bind the cytoplasmic tail of membrane-type 1 matrix metalloproteinase (MT1-MMP/ MMP14) and act as a negative regulator by inhibiting MT1-MMPmediated cellular invasion (Uekita et al., 2004) . The gene ADI1 encoding ARD is downregulated in rat prostate and human prostate cancer cell lines and enforced expression of ADI1 induces apoptosis (Oram et al., 2007) . Cultured gastric carcinoma cells and fibrosarcoma cells also have downregulated ADI1 (Oram et al., 2004) . A recent study examining the impact of genetic polymorphism on the relationship between exposure to environmental carcinogens and gene expression has shown that the gene ADI1 has a direct link with cancer development (Espin-Perez et al., 2015) . These studies suggest that ARD plays an inhibitory role in tumor progression.
In order to understand the molecular mechanisms involved in determining the role of HsARD in cancer, we deemed it important to biochemically and structurally characterize this important enzyme. HsARD is a 21 498 Da protein which shares an 84% sequence identity to MmARD and 28% sequence identity with K. oxytoca ARD (KoARD) (Fig. 3) 
Materials and Methods

Cloning
The HsARD gene was obtained from the Pochapsky lab at Brandeis University. The gene was amplified using the primers 5′-CCATGGCAAGTTGGAGCCACCCGCAGTTCGAGAAG-3′ and 5′-GGCACAGACCGCATAGGAATTC-3′ and cloned into pET28a (Merck Millipore, Darmstadt, Germany) via the restriction sites NcoI and XhoI. Using the appropriate primers, an eight amino acid Strep II affinity tag (Trp-Ser-His-Pro-Gln-Phe-Glu-Lys) was placed on the N-terminus of the protein. This tag binds with high affinity to Strep-Tactin, an engineered streptavidin (IBA Life Sciences). All sequences were confirmed by standard methods.
Single-metal expression and purification of HsARD
The plasmid encoding Strep-HsARD was transformed into E. coli RIPL (Agilent Technologies) strain cells and plated onto minimal media without metal supplements. The different metal ion-bound ARD proteins were expressed in M9 minimal media (6 g/L Na 2 HPO 4 , 3 g/L KH 2 PO 4 , 1 g/L NH 4 Cl, 0.5 g/L NaCl, 2 mM MgSO 4 , 0.1 mM CaCl 2 ) with 0.4% glucose as the carbon source. The appropriate metal was added to the medium at induction and purifications conducted as described in Deshpande et al. (2016) . Fe 2+ -bound HsARD was purified in anaerobic conditions as described below. For the 15 N-labeled HsARD isozymes, the M9 minimal media was prepared with 15 NH 4 Cl (Cambridge Isotope Laboratories, Andover, MA) as the sole nitrogen source.
Anaerobic purification of Fe 2+ -bound HsARD
The buffers used for purification of Fe-HsARD were degassed and argon saturated. The harvested cells were suspended in wash buffer 100 mM HEPES, pH 7.0, 100 mM NaCl with protease inhibitors (Roche protease inhibitor cocktail EDTA-free) and sonicated for 5 min. All the subsequent purification steps were performed in a Coy anaerobic chamber (Coy Manufacturing, Ann Arbor, MI) to maintain anaerobic conditions. The cell extract was collected anaerobically in a centrifuge tube to maintain an anaerobic head space during centrifugation. The supernatant collected after centrifugation was passed through Strep-Tactin resin (IBA Life Sciences) which were pre-equilibrated with the wash buffer. The resin was washed with five column volumes (CVs) of wash buffer and eluted with two CV of elution buffer 100 mM HEPES, pH 7.0, 10 mM D-desthiobiotin. The eluent was buffer-exchanged into the storage buffer (50 mM HEPES, pH 7.0, 100 mM NaCl) using Millipore Amicon concentrators which were pre-equilibrated with degassed and Ar-saturated storage buffer to remove the dissolved oxygen in the membrane. The pooled sample was concentrated and stored anaerobically at −80°C. 
Enzymatic activity assay
As acireductone is oxidatively unstable and cannot be stored, it must be generated in situ for enzymatic assays by the action of E1 enolase phosphatase on precursor (1-Phosphonooxy-2,2-dihydroxy-3-oxohexane) prior to addition of ARD. E1 and 1-Phosphonooxy-2,2-dihydroxy-3-oxohexane were prepared as described in Zhang et al. (2004) (Fig. 4) . The enzymatic assay to measure ARD activity was performed as previously described (Deshpande et al., 2016) . All experiments were performed in the assay buffer 50 mM HEPES pH 7.0, 1 mM MgCl 2 .
Product quantification assays
The off-pathway reaction product butyric acid derived from desthioacireductone (1,2-dihydroxy-3-keto-hex-1-ene) substrate was quantified by high pressure liquid chromatography using a Biorad Aminex HPX-87 organic acid column (300 × 7.8 mm). The column was eluted using 5 mM H 2 SO 4 at 0.3 mL/min. Butyric acid elutes at a retention time of~45 min.
Metal content analysis
The metal content in each protein sample was measured using inductively coupled plasma mass spectrometry (ICP-MS). The measurements were performed at Harvard School of Public Health using a Perkin Elmer Elan DRC-II ICP-MS instrument. The protein sample preparation and ICP-MS measurements were performed as previously described (Deshpande et al., 2016) .
Thermal stability
Thermal stability of purified HsARD samples was measured using differential scanning fluorimetry (DSF) performed on a StepOnePlus™ Real-Time PCR System (Applied Biosystems). The samples for analysis were set up in a 96-well plate with each well containing 20 µM protein with 10× SYPRO Orange (Invitrogen) in final volume of 25 µL. The samples were heated at a ramp rate of 0.3°C/min and a temperature range of 25-90°C. The fluorescence data generated was normalized and plotted for each metal ionbound HsARD.
Oligomeric state
The oligomeric state of HsARD proteins bound to different metal ions was determined using analytical gel filtration. The samples were concentrated to 30-100 µM and loaded onto a Superdex 200 5/150 GL column (GE Healthcare Life Sciences) equilibrated with 50 mM HEPES pH 7.0, 100 mM NaCl. A calibration curve was generated using a set of low-molecular-weight protein standards (GE Biosciences) ribonuclease A (13.7 kDa), carbonic anhydrase (29 kDa), ovalbumin (44 kDa 
Enzymatic activity
The different metal ion-bound HsARD isozymes were measured for specific activity using the substrate depletion enzymatic assay (Fig. 5) . The enzymatic activity of HsARD is metal ion co-factor dependent and the activity trend is similar to MmARD (Fe
). Although the specific activity of Co-HsARD is higher than Ni-HsARD, after correction for metal ion occupancy, the two isozymes exhibit similar activity. 
Enzymatic product analysis
The desthio-product butyric acid from the off-pathway reaction of desthio-acireductone was quantified and the results are summarized in Fig. 6 . The bacterial proteins from K. oxytoca Fe-KoARD and Ni-KoARD were used as controls to confirm that the assays are working. The data clearly demonstrate that Fe-HsARD exhibits onpathway chemistry and Ni-HsARD, Co-HsARD and Mn-HsARD exhibit off-pathway chemistry. HsARD exhibits the same metal iondependent dual chemistry as the bacterial enzyme KoARD and mammalian enzyme MmARD.
Relative thermal stability of HsARD bound to specific metal ions
The thermal stability of each metal ion-bound HsARD was established using DSF (Niesen et al., 2007) . Similar to MmARD, the data (Fig. 7) indicated that Ni-HsARD is the most thermostable, followed by Co-HsARD, while Mn-HsARD exhibited the least thermal stability. These differences in the melting temperatures likely reflect the binding affinity of a given metal ions for the apo-protein.
Oligomeric state of HsARD bound to specific metal ions
To investigate whether the oligomeric state of HsARD changes upon binding different metal ions, analytical gel filtration was used to estimate the molecular weights of each of the metal ion-bound HsARD isozymes. All the metal constituted HsARD proteins exhibited a molecular weight of the monomer except Mn-HsARD which eluted with a size of 19 KDa. This difference of 10 KDa in the molecular weight may may reflect the lower stability of the Mnbound enzyme, with possible unfolding occurring during the experiment. The assay was performed in argon-saturated 50 mM HEPES pH 7.0, 1 mM MgCl 2 buffer with 0.6 µM E1 enzyme, 500 µM E1 substrate in a total volume of 1 mL. A controlled amount of ARD was added and the depletion of acireductone was monitored spectrophotometrically at 308 nm. The errors are represented as standard deviations of three replicates. Fig. 6 Off-pathway product analysis of different metal ion-bound HsARDs. The enzymatic reaction mixture contained argon-saturated 50 mM HEPES pH 7.0, 1 mM MgCl 2 buffer with 0.3 µM E1 enzyme, 250 µM E1 substrate in a total volume of 1 mL. About 100 µL of this reaction mixture was loaded onto the organic acid column. The quantitation is based on a 1 mL reaction mixture. The errors are represented as standard deviations of three replicates. 
Solution NMR data of different metal ion-bound HsARD enzymes NMR spectroscopy can provide significant insights into the folding and integrity of protein structure. Ideally, a two-dimensional 15 N, 1 H HSQC spectrum shows a correlation for each backbone amide N-H in the protein (as well as side chain glutamine and asparagine NH 2 groups). As the chemical shift dispersion in the spectrum is reflective of the local structural environment, comparison of the HSQC spectra of the different metal ion-bound forms of HsARD provides a rapid evaluation of structural differences (if any) between the isozymes. The dispersion apparent in the Fe-HsARD, Ni-HsARD and Co-HsARD HSQC spectra is typical of well-folded proteins, with peaks downfield of 8 ppm in the 1 H dimension (to the left along the horizontal axis) likely representing linearly hydrogen bonded NH groups that occur in β-sheets or tight turns, while those between 6-8 ppm typical of helical or coiled regions. The Mn-HsARD isozyme shows significantly fewer correlations, but whether this is due to the lower stability of the protein (Fig. 6) or the expected high-spin (S = 5/2) of Mn 2+ ion in the active site resulting in long-range paramagnetic relaxation will require a more thorough analysis. Differences in magnetic anisotropy of the various metal ions may also contribute to spectral differences near the metal-binding site. Nevertheless, the lack of overlap between many HSQC correlations in the Fe-HsARD and Ni-HsARD isozymes indicates significant differences in the different metal ion-bound HsARD structures (Fig. 8 ).
Structural differences are further indicated by the upfield shifted regions (<0 ppm) of the one-dimensional 1 H spectra of the isozymes. This spectral region typically shows the signals of methyl groups (valine, leucine and isoleucine) that pack against aromatic rings (phenylalanine, tyrosine and tryptophan) in hydrophobic core regions of the fold. In the case of KoARD, these differences were observed due to the metal-dependent repacking of a secondary hydrophobic core on one face of the β-barrel structure (Ju et al., 2006) . It is likely that the same regions are responsible for the metal-dependent spectral differences observed for HsARD as well.
Discussion and conclusion
Enzymatic activity of HsARD is metal ion dependent
In this study, we were able to purify one isoform of metal ion-bound HsARD using minimal media expression in the presence of a single metal ion. The metal occupancies were lower than 1 mole metal ion/ mole protein except for Co 2+ . Unlike MmARD, Cu 2+ was not incorporated into HsARD. As seen in MmARD, Fe-HsARD has the highest activity compared to Ni-HsARD, Co-HsARD or Mn-HsARD. This is in contrast to ARD in K. oxytoca, where Ni-KoARD has a higher activity than Fe-KoARD (Dai et al., 2001) . Biochemical studies on ARD from Oryza sativa L. (OsARD) have shown that Ni-OsARD polymerizes and has a much reduced activity relative to Fe-OsARD (Sauter et al., 2005) . Hence we speculate that the off-pathway chemistry may be relevant only in pathology in mammals or eukaryotes, unlike in bacteria (K. oxytoca) where it has been shown that the dual chemistry is seen in the native organism. Under normal conditions, therefore, it is expected that Fe 2+ is the native metal ion co-factor in eukaryotes.
Human ARD is capable of performing metal ion-dependent dual chemistry
The data presented here clearly show that, as for MmARD and KoARD, HsARD exhibits metal ion-dependent on-and off-pathway chemistry in vitro. HsARD also exhibits the same metal ion-binding promiscuity seen in KoARD and MmARD, with similar patterns of metal ion-dependent thermostabilites. The dual chemistry of HsARD is interesting since carbon monoxide (CO) which is a product of the off-pathway chemistry is known to be an anti-apoptotic molecule and has been proposed to act as a signaling molecule in mammals (Verma et al., 1993; Thom et al., 2000; Gunther et al., 2002; Liu et al., 2002) and several studies have indicated a role for HsARD in cancer (Uekita et al., 2004; Oram et al., 2007) . This leads to the intriguing possibility that the off-pathway chemistry catalyzed by the Ni HsARD active site could help protect tumor cells from apoptosis by producing carbon monoxide. Ni is known to be toxic and carcinogenic, and no native Ni-binding metalloenzyme has yet been found in mammals. However, since off-pathway chemistry is seen also with Co-HsARD and Mn-HsARD, it will be interesting to test for the presence of off-pathway HsARD chemistry in vivo in methionine dependent cancer cell lines.
Metal-dependent structural perturbations are observed in HsARD
The NMR data presented here provide preliminary evidence of significant structural differences between some of the different metal ion-bound HsARD isoforms. Inspection of both the upfield region of 1D spectra and 2D 1 H, 15 N HSQC spectra of Mn-HsARD, FeHsARD, Co-HsARD and Ni-HsARD isozymes provides evidence for these differences. We are currently performing sequential resonance assignments of Fe-HsARD, Co-HsARD and Ni-HsARD proteins preliminary to obtaining solution structures of the three HsARD isoforms. To date, the only available structure of HsARD is a low-resolution crytstallographic (3.05 Å) structure (PDB ID: 4QGN). The complete details of this structure have not been published but the bound metal ion is proposed to be Fe
3+
. This is surprising to us, since we have found that the Fe 3+ form of the enzyme is unstable and inactive. A homology model of HsARD created using the Ni 2+ -bound MmARD (PDB code 5I8S) is shown in Fig. 9 .
The structures of the Ni 2+ (PDB ID: 1ZRR) and Fe 2+ (PDB ID:
2HJI) forms of ARD from K. oxytoca have been solved by solution NMR spectroscopy (Pochapsky et al., 2002; Ju et al., 2006) . While Fe-KoARD was difficult to characterize structurally, as it tended to decompose during long NMR acquisitions, (Ju et al., 2006) FeHsARD is relatively stable under anaerobic conditions over the course of the NMR experiments described here. Fe-HsARD is, as such, a promising target for a more complete structural work.
Close inspection of both the 1D and 2D NMR spectra of metal isoforms of HsARD in Fig. 8 (Crans et al., 2003) , suggesting that the spectral differences between the Fe 2+ and Ni 2+ HsARD isoforms reflect genuine structural differences, similar to what was observed in the bacterial ARD enzymes (Ju et al., 2006) . Finally, Co 2+ -HsARD (S = 3/2) will likely exhibit significantly different pseudocontact 1 H shifts than the Ni-bound enzyme, based on the results from the model complexes referenced above. So while the similarity between the crystallographic structures of Ni-MmARD and Co-MmARD (RMSD = 0.06 Å) may be to some extent crystallographically artifactual, resolving this issue must await the results of a more complete NMR structural characterization.
Potential 'moonlighting' functions of HsARD
HsARD has been shown to serve regulatory functions in addition to its enzymatic function in the MSP. HsARD binds to the cytoplasmic tail of membrane-type 1 matrix metalloproteinase (MT1-MMP) and inhibits MT1-MMP-mediated cellular invasiveness (Uekita et al., 2004) . ADI1 encoding ARD is downregulated in rat prostate and human prostate cancer cell lines and its enforced expression induces apoptosis (Oram et al., 2007) . An N-terminal truncated version of HsARD called SipL was shown to be implicated in the replication of hepatitis C virus in non-permissive cell lines. This truncated version of HsARD is missing 63 amino acids at the N-terminal end (Yeh et al., 2001) . Assuming that the SipL variant folds similar to the full-length HsARD, the intact β-barrel is present in the SipL variant. It is unknown if SipL is a metalbinding protein or if it maintains enzymatic activity. A recent clinical study related these two regulatory functions of HsARD, showing that the physical interaction between MT1-MMP and ADI1 leads to suppression of hepatitis C infection and this inhibitory effect could be reversed by ADI1 overexpression (Yeh et al., 2008) . ADI1 was also shown to be required for normal Drosophila fecundity (Chou et al., 2014) . Under conditions of dietary restriction, the egg production of acireductone dioxygenase 1 (DADI1) deficient flies was reduced compared to that of control flies. This fecundity defect in mutant flies was rescued by either supplementing with methionine or reintroduction of the DADI1 gene. A functional homolog of human ADI1 was also able to rescue the fecundity defect. This shows that ARD is multifunctional, acting both as an enzyme and a regulatory protein. This leads to interesting questions such as: Do each of these functions have a different mechanism or are they interrelated? Are these functions performed in different subcellular compartments? Are these non-enzymatic functions dependent on the enzymatic activity of ARD? Future work can be addressed towards delineating some of these functions of ARD and identifying regions of the protein that are involved in the regulatory functions of ARD.
